Solutions - Abzena

Let's turn ideas into solutions.

Integrated biologic and bioconjugate solutions that help overcome development challenges, accelerate program success, and move new medicines forward for patients in need.

Download Brochure

One Integrated CDMO + CRO Partner. Reduced Risk. Unparalleled Expertise.

Meeting your challenges

Breakthroughs rarely happen in silos. The most creative ideas and innovative solutions emerge from diverse perspectives and collaborative energy. Our proactive solutions can accelerate your ideas from discovery and development, through to commercialization and launch. No matter the challenge, Abzena are always focused on understanding and delivering on your program’s goals across all development stages.

Abzena are uniquely positioned, and ready to partner with you, to move your complex biologic or bioconjugate program’s forward. When you partner with us, expect:

Access to Genuine Scientific & Technical Experts
Proactive Solutions for Streamlining Development
Diverse and Interconnected Teams
End-to-End Support Under One Organization

Explore our solutions below and see how we can help you accelerate your drug development program.

Explore Our Innovative Solutions

AbZelectPRO™: GMP-Ready, High-Yielding Cell Line Development Platform

Move your cell line development efficiency forwards with our AbZelectPRO™ platform.

Learn More

ThioBridge®: Linking Antibody-to-Drug with ThioBridge® Conjugation Technology for Better ADCs & AOCs

Enhance your ADC & AOC design & delivery development with our ThioBridge® conjugation platform technology.

Learn More

EpiScreen® 2.0: Smarter Immunogenicity Testing

A comprehensive suite of assays that predict and evaluate potential risks of preclinical immunogenicity in protein, antibody, and gene therapy therapeutics.

Learn More

LabZient™: Rapid Analytical Data

LabZient™ sets a new standard in the field of biopharmaceutical analysis offering a cost-effective, efficient, and scientifically sound path to clinical trial readiness.

Learn More

Composite Human Antibody™ (CHAb): Advanced Antibody Humanization

Design safer, more effective, humanized antibodies. Composite Human Antibody™ technology combines humanization & deimmunization technologies.

Learn More

Composite Proteins™: Effective Deimmunized Proteins

Our Composite Proteins™ technology generates therapeutic proteins designed to minimize immunogenicity in patients without compromising protein activity.

Learn More

We are ready to accelerate your drug development program

Solutions that meet your goals, development phase challenges and minimize risk.

No matter the challenge, our integrated solutions can help accelerate your drug program from early discovery and development, through to commercialization. Discover how we can help your success.

How can we rapidly advance our next-generation biologic or bioconjugate?

Abzena is focused on finding the right solution, at the right development stage, that delivers on your goals. Whether you are looking to progress through hit-to-lead candidate discovery faster, accelerate your preclinical DNA-IND/CTA enabling programs, or are searching for a commercial launch partner – or have a question about the best strategy for your molecule type – our experts are ready to help meet your drug development goals.

What are your goals?
Move forward from Hit-to-Lead Candidate faster Move forward from DNA to IND/CTA faster Move forward from IND-to-BLA faster Move forward to Commercialization faster

Drug Developability: the Derisker

Starting smart, finishing fast, with Abzena.

Drug Developability: the Derisker

Why Abzena?

We are the leading biologic, bioconjugate and ADC CDMO + CRO who anticipates and meets your drug development challenges. Find out more about who Abzena are and why, together, we can make a difference to patients lives and move medicine forwards.

When you partner with us, expect:

Access to Genuine Scientific & Technical Experts
Proactive Solutions for Streamlining Development
Diverse and Interconnected Teams
End-to-End Support Under One Organization

Why Abzena?

Discovery & Manufacturing Facilities

Tour Our Facilities

San Diego, CA, USA

Development, Manufacturing

Abzena San Diego boasts a trio of cutting-edge facilities designed to accelerate the development, production, and testing of biologics. 

Tour Our Facilities Visit San Diego, CA, USA

Bristol, PA, USA

Discovery, Manufacturing

At Abzena Bristol, we specialize in bioconjugation, quality linker payloads, highly potent materials and complex chemistry.

Tour Our Facilities Visit Bristol, PA, USA

Cambridge, UK

Development, Discovery

Abzena Cambridge specializes in the early discovery, design, and development of complex biologics and bioconjugates.

Tour Our Facilities Visit Cambridge, UK

Raleigh, NC, USA

Discovery, Manufacturing

At Abzena Bristol, we specialize in bioconjugation, quality linker payloads, highly potent materials and complex chemistry.

Tour Our Facilities Visit Raleigh, NC, USA

Featured News & Insights

Blog

Getting Bispecific Antibody Release Testing Right

Read More

Articles

The Medicine Maker: Capabilities for a Changing Landscape

Read More

Articles

Pharma’s Almanac: How are Geopolitical Factors Influencing Sourcing & Manufacturing Decisions for 2026 and Beyond?

Read More

Moving medicine forwards.

It’s what we do. At Abzena, we know how to take your ideas forward and develop a successful medicine of the future.

Contact Us

Together, we can keep moving medicine forward.

The leading biologics CDMO + CRO that accelerates drug development, moving medicine forward for patients in need.